AbVitro's Acquisition

AbVitro was acquired by Juno Therapeutics on January 11, 2016.

AbVitro's cutting edge technology platform accelerates the development of novel immunotherapies by identifying cancer-specific immune cells from natural immune responses at unprecedented resolution. B…

Articles about AbVitro's Acquisition: